IP Library Granted Patent US 9,395,366
Granted Patent B2
US 9,395,366 · App. 14/598,621 · Granted Jul 19, 2016

Non-heating detection method for dermatophyte

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,395,366
App. No.
14/598,621
Granted
Jul 19, 2016
Kind
B2
Abstract

The present invention provides a method of detecting dermatophyte, which does not require a complicated operation such as an enzyme treatment and a heat treatment. The present invention provides a method of detecting dermatophyte, including a step of extracting a dermatophyte component from a sample with a treatment liquid containing a non-ionic surfactant or a zwitterionic surfactant, and a kit for diagnosing dermatophyte infection, containing a treatment liquid comprising the above surfactant, and an antibody specifically recognizing a dermatophyte component, which are housed in separate containers.

Claims (7)

1. A method of detecting dermatophyte, comprising the following steps:

(a) a step of extracting a dermatophyte component from a sample selected from group consisting of skin, nail, scale, hair and pelage with a treatment liquid comprising 0.5-5.0 wt % of n-octyl-β-D-glucoside at a temperature of 4° C.-45° C.,

(b) a step of forming a complex by contacting the dermatophyte component obtained in said step (a) with an antibody produced by hybridoma 0014, and

(c) a step of detecting the complex formed in said step (b).

2. The method of claim 1 , wherein the treatment liquid comprises 0.5-2.0 wt % of n-octyl-β-D-glucoside.

3. A kit for diagnosing dermatophyte infection, comprising a treatment liquid comprising 0.5-5.0 wt % of n octyl-β-D-glucoside and an antibody produced by hybridoma 0014, which are housed in separate containers.

4. The kit for diagnosing dermatophyte infection according to claim 3 , wherein the treatment liquid comprises 0.5-2.0 wt % of n-octyl-β-D-glucoside.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2023
From: JNC CORPORATION
To: MARUHO CO., LTD.
Reel/Frame 064890/0774 →